AgingResearch.NewsJoin free

Coefficient of variation of fasting plasma glucose

Biomarker

2 papers3 findings

  • Humans2

Effects

1

Malignancy-related mortality

no changein humans1

1 study

  1. Coefficient of variation of fasting plasma glucose has no effect on malignancy-related mortality in humans.

    “Diabetes- and malignancy-related mortality were not independently associated with any parameter of glucose control”

    Humansin elderly patients with NIDDM5 yearsn = 566

    Long-term instability of fasting plasma glucose, a novel predictor of cardiovascular mortality in elderly patients with non-insulin-dependent diabetes mellitus: the Verona Diabetes Study

    Circulation16 Sep 1997

Associations

2

Cardiovascular-related mortality

upin humans1RR 2.4

1 study

  1. Coefficient of variation of fasting plasma glucose raises the risk of cardiovascular-related mortality in humans (RR 2.40, 95% CI 1.28 to 4.53).

    “the relative risk of cardiovascular mortality in subjects in tertile III versus tertile I of CV-FPG was 2.40 (95% CI, 1.28 to 4.53).”

    Humansin elderly patients with NIDDM5 yearsn = 566

    Long-term instability of fasting plasma glucose, a novel predictor of cardiovascular mortality in elderly patients with non-insulin-dependent diabetes mellitus: the Verona Diabetes Study

    Circulation16 Sep 1997

Mortality

upin humans1

1 study

  1. Coefficient of variation of fasting plasma glucose predicts mortality in humans.

    “Kaplan-Meier survival analysis indicated that patients with high CV-FPG as well as those in tertiles I and III of S-FPG”

    Humanstype 2 diabetes mellitus1 January 1987 to 31 December 1991n = 566

    Long-term instability of fasting plasma glucose predicts mortality in elderly NIDDM patients: the Verona Diabetes Study

    Diabetologia1 Jun 1995

Latest

Related